摘要
目的:探讨环孢素A联合司坦唑醇片治疗慢性再生障碍性贫血的临床疗效。方法:将40例慢性再生障碍性贫血患者随机分为观察组和对照组各20例,观察组给予环孢素A联合司坦唑醇片治疗,对照组给予十一酸睾酮治疗,比较2组患者的临床效果及用药后的不良反应。结果:观察组患者的总有效率为100%,对照组患者的总有效率为75%,观察组显著优于对照组,2组比较,差异具有统计学意义(P<0.05)。结论:环孢素A联合司坦唑醇片治疗慢性再生障碍性贫血的临床效果明显优于十一酸睾酮治疗,且安全有效,无严重不良反应,值得临床推广应用。
Objective： To explore cyclosporin A joint Stanozolol Tablets in the treatment of chronic aplastic anemia clinical curative effect. Methods： 40 cases of chronic aplastic anemia patients were randomly divided into observation group and control group the 20 cases, observation group was given cyclosporin A Stanozolol Tablets combined treatment group, give Testosterone Undecanoate treatment, compared two groups of patients and the clinical effect of when the drug adverse reactions. Results：The observation group of patients with total effective rate was 100%, in the patients in the total effective rate was 75%, the observation group was superior to control group, two groups of comparisons, a statistically significant difference （P 〈 0.05）. Conclusions： Cyclosporin A joint Stanozolol Tablets in the treatment of chronic aplastic anemia was obviously better than the clinical effect of Testosterone Undecanoate treatment, safe and effective, no serious adverse reaction, it should be worth clinical application.
出处
《中国伤残医学》
2013年第2期19-21,共3页
Chinese Journal of Trauma and Disability Medicine
